
5-Amino-4-imidazolecarboxamide
CAS No. 21299-72-9
5-Amino-4-imidazolecarboxamide( —— )
Catalog No. M13390 CAS No. 21299-72-9
An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 45 | In Stock |
![]() ![]() |
25MG | 61 | In Stock |
![]() ![]() |
50MG | 98 | In Stock |
![]() ![]() |
100MG | 129 | In Stock |
![]() ![]() |
200MG | 181 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name5-Amino-4-imidazolecarboxamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.
-
DescriptionAn imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number21299-72-9
-
Formula Weight126.12
-
Molecular FormulaC4H6N4O
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESCl.NC(=O)C1=C(N)N=CN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
3-O-Methylviolanone
3'-O-methylviolanone has anti-inflammatory activity.
-
CRF, bovine TFA (923...
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. CRF shows pEC50s of 11.16, 8.53 and 8.70 for human CRF1, human CRF2 and rat CRF2α.
-
FL118
FL118 is a novel survivin inhibitor that inhibits cancer stem cell-like properties.FL118 is a novel camptothecin analog with anticancer activity that inhibits epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway, thereby inhibiting migration and invasion of human breast cancer cells.